Vericel's stock surged 5.38% during pre-market trading on Thursday, following the release of its first-quarter financial results for fiscal year 2026.

The company reported robust growth, with revenue increasing by 30% year-over-year to $68.4 million, surpassing analyst estimates. The net loss narrowed significantly to $6.3 million, while gross margin improved by 3 percentage points to 72%. Adjusted EBITDA more than doubled to $9.6 million, and free cash flow turned positive at $15.1 million.

Notably, Vericel raised its full-year revenue guidance by $10 million, signaling strong confidence in its future performance. The positive market reaction reflects investor approval of the company's improved profitability metrics and upwardly revised outlook.